Detalles de la búsqueda
1.
Systemic lupus erythematosus phenotypes formed from machine learning with a specific focus on cognitive impairment.
Rheumatology (Oxford);
62(11): 3610-3618, 2023 11 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36394258
2.
Association of mycophenolate and azathioprine use with cognitive function in systemic lupus.
Rheumatology (Oxford);
62(5): 1860-1869, 2023 05 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36135792
3.
Serological abnormalities that predict progression to systemic autoimmune rheumatic diseases in antinuclear antibody-positive individuals.
Rheumatology (Oxford);
61(3): 1092-1105, 2022 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34175923
4.
Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus.
Lupus;
31(1): 45-54, 2022 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-34957878
5.
Validity and reliability of patient reported outcomes measurement information system computerized adaptive tests in systemic lupus erythematous.
Lupus;
30(13): 2102-2113, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34797991
6.
The Effects of Systemic Lupus-Related Cognitive Impairments on Activities of Daily Living and Life Role Participation: A Qualitative Framework Study.
ACR Open Rheumatol;
6(1): 21-30, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37964675
7.
OMERACT 2023 Systemic Lupus Erythematosus Special Interest Group: Winnowing and Binning Preliminary Candidate Domains for the Core Outcome Set.
Semin Arthritis Rheum;
65: 152380, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38281467
8.
Interferon and interferon-induced cytokines as markers of impending clinical progression in ANA+ individuals without a systemic autoimmune rheumatic disease diagnosis.
Arthritis Res Ther;
25(1): 21, 2023 02 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36765391
9.
Centrally acting ACE inhibitor (cACEi) and angiotensin receptor blocker (cARB) use and cognitive dysfunction in patients with SLE.
Lupus Sci Med;
10(2)2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37429671
10.
Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus.
Arthritis Care Res (Hoboken);
75(3): 569-577, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35724303
11.
Serum S100A8/A9 and MMP-9 levels are elevated in systemic lupus erythematosus patients with cognitive impairment.
Front Immunol;
14: 1326751, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-38332909
12.
Herpes zoster in SLE: prevalence, incidence and risk factors.
Lupus Sci Med;
9(1)2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35017186
13.
Identification and Validation of a Urinary Biomarker Panel to Accurately Diagnose and Predict Response to Therapy in Lupus Nephritis.
Front Immunol;
13: 889931, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35711439
14.
Altered Balance of Pro-Inflammatory Immune Cells to T Regulatory Cells Differentiates Symptomatic From Asymptomatic Individuals With Anti-Nuclear Antibodies.
Front Immunol;
13: 886442, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35844549
15.
Longitudinal relationships between cognitive domains and depression and anxiety symptoms in systemic lupus erythematosus.
Semin Arthritis Rheum;
51(6): 1186-1192, 2021 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34607183
16.
Insight into intraindividual variability across neuropsychological tests and its association with cognitive dysfunction in patients with lupus.
Lupus Sci Med;
8(1)2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34610995
17.
Validity Evidence for the Use of Automated Neuropsychologic Assessment Metrics As a Screening Tool for Cognitive Impairment in Systemic Lupus Erythematosus.
Arthritis Care Res (Hoboken);
72(12): 1809-1819, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31628718
18.
Assessment of the psychometric properties of patient-reported outcomes of depression and anxiety in systemic lupus erythematosus.
Semin Arthritis Rheum;
49(2): 260-266, 2019 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-30940467
19.
Fatigue severity in anti-nuclear antibody-positive individuals does not correlate with pro-inflammatory cytokine levels or predict imminent progression to symptomatic disease.
Arthritis Res Ther;
21(1): 223, 2019 11 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31685018
20.
The presence of anti-nuclear antibodies alone is associated with changes in B cell activation and T follicular helper cells similar to those in systemic autoimmune rheumatic disease.
Arthritis Res Ther;
20(1): 264, 2018 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-30486869